Ochsner Health
Ochsner Health System Formulary
Formulary Addition Request
Questions or Suggestions?
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
HazD
Look Alike Sound Alike
Ambulatory
Do Not Crush
REMS
Antibiotic IV Push Administration
Vaccine
SDS Online
Do Not Crush
OHS Pharmacy Contact
Louisiana Poison Control(800) 222-1222
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Ochsner Health COVID-19 SharePoint Site
"Safety On Site"
Click here
to enter an S.O.S.
Physician
Nurse
Partners
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local
pharmacy
for available inventory.
Ochsner Health
Ochsner Health System Formulary
Formulary Addition Request
Questions or Suggestions?
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
HazD
Look Alike Sound Alike
Ambulatory
Do Not Crush
REMS
Antibiotic IV Push Administration
Vaccine
SDS Online
Do Not Crush
OHS Pharmacy Contact
Louisiana Poison Control(800) 222-1222
Webpage Links
HazD
Please review each of these drugs carefully.
abacavir
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
abiraterone
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
ado-trastuzumab emtansine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
afatinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
aflibercept ophthalmic
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
ambrisentan
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
amivantamab
PPE, Disposal, and Assessment of Risk
anastrozole
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
apomorphine
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
arsenic trioxide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
axitinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
azaCITIDine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
azaTHIOprine
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
belantamab mafodotin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
belinostat
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
bendamustine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
bexarotene
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
bicalutamide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
bleomycin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
bortezomib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
bosentan
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
bosutinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
brentuximab vedotin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
busulfan
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
cabazitaxel
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
cabergoline
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
cabozanrinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
calaspargase pegol
PPE, Disposal, and Assessment of Risk
capecitabine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
capsaicin topical
capsaicin hd (8%) PPE, Disposal, and Assessment of Risk
carBAMazepine
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
CARBOplatin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
carfilzomib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
carmustine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
chlorambucil
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
chloramphenicol
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
chorionic gonadotropin (HCG)
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
cidofovir
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
CISplatin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
cladribine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
clofarabine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
clonazePAM
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
colchicine
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
conjugated estrogens
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
crizotinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
cyclophosphamide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
cycloSPORINE
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
cytarabine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
cytarabine liposomal
Group 1: Antineoplastic
dabrafenib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
dacarbazine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
DACTINomycin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
dasatinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
DAUNOrubicin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
daunorubicin-cytarabine (liposomal)
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
decitabine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
degarelix
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
desogestrel-ethinyl estradiol
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
dexrazoxane
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
dinoprostone topical
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
divalproex sodium
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
DOCEtaxel
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
DOXOrubicin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
DOXOrubicin liposomal
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
dronedarone
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
dutasteride
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
entecavir
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
enzalutamide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
epiRUBicin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
eriBULin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
erlotinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
eslicarbazepine
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
esterified estrogens-methyltestosterone
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
estradiol
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
estradiol topical
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
estropipate
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
ethinyl estradiol-norethindrone
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
etonogestrel
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
etoposide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
etoposide phosphate
Group 1: Antineoplastic
everolimus
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
exemestane
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
fam-trastuzumab deruxtecan
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
finasteride
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
fingolimod
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
fluconazole
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
fludarabine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
fluorouracil
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
flutamide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
fosphenytoin
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
fulvestrant
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
ganciclovir
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
gemcitabine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
gemtuzumab ozogamicin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
goserelin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
histrelin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
HYDROXYprogesterone
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
hydroxyurea
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
icatibant
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
IDArubicin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
ifosfamide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
imatinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
inotuzumab ozogamicin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
irinotecan
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
irinotecan liposomal
Group 1: Antineoplastic
ixabepilone
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
ixazomib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
leflunomide
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
lenalidomide
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
letrozole
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
leuprolide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
levonorgestrel
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
lomustine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
loncastuximab tesirine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
macitentan
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
margetuximab
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
medroxyPROGESTERone
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
megestrol
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
melphalan
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
mercaptopurine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
methIMAzole
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
methotrexate
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
methylergonovine
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
midostaurin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
miFEPRIStone
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
mirvetuximab soravtansine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
miSOPROStol
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
mitoMYcin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
mitoMYcin ophthalmic
PPE: Disposal and Assessment of Risk
Group 1: Antineoplastic
mitoXANTRONE
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
mycophenolate mofetil
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
mycophenolic acid
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
nelarabine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
nevirapine
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
nilotinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
nivolumab-relatlimab
Under review
norethindrone
Norethindrone - PPE, Disposal, and Assessment of Risk
Ethinyl Estradiol - PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
obinutuzumab
omacetaxine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
oxaliplatin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
OXcarbazepine
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
oxytocin
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
PACLitaxel
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
PACLitaxel protein-bound
Group 1: Antineoplastic
pamidronate
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
PARoxetine
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
PAZOPanib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
pegaspargase
PPE, Disposal, and Assessment of Risk
PEMEtrexed
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
pentostatin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
pertuzumab
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
phenoxybenzamine
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
phenytoin
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
plerixafor
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
polatuzumab vedotin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
PONATinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
PRALAtrexate
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
progesterone
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
propylthiouracil
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
raloxifene
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
rasagiline
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
regorafenib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
ribavirin
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
riociguat
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
risperiDONE
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
romiDEPsin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
sirolimus
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
SORAfenib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
spironolactone
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
streptozocin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
SUNItinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
tacrolimus
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
tamoxifen
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
teclistamab
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
temazepam
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
temozolomide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
temsirolimus
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
teniposide
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
teriflunomide
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
testosterone
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
thalidomide
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
thiotepa
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
tisotumab vedotin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
tofacitinib
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
topiramate
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
topotecan
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
trabectedin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
trametinib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
tremelimumab
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
tretinoin
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
triptorelin
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
ulipristal
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
valGANciclovir
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
valproic acid
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
vigabatrin
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
vinBLAStine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
vinCRIStine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
vinCRIStine liposome
Group 1: Antineoplastic
vinorelbine
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
vismodegib
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
voriconazole
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
warfarin
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
zidovudine
PPE, Disposal, and Assessment of Risk
Group 2: Non-Antineoplastic
ziprasidone
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
ziv-aflibercept
PPE, Disposal, and Assessment of Risk
Group 1: Antineoplastic
zoledronic acid
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity
zonisamide
PPE, Disposal, and Assessment of Risk
Group 3: Reproductive Toxicity